Mission: We study the structural mechanisms of viral infection and other diseases of global health concern, and translate our discoveries into therapeutic strategies.
Scope: We work on viral proteins, not live viruses.
Fang Li, PhD
- Professor and Endowed Chair, Pharmacology, University of Minnesota
- Director, Center for Emerging Viruses
- Founder and CEO, Nanoli Therapeutics
- Co-Director, Midwest Antiviral Drug Discovery Center
Research Highlights:
- Structural Biology of Virus Entry and Antiviral Development
- Pandemic Research from the Li Lab
- How Deadly Marburg Virus Enters Human Cells
- Top Eleven Most Important Publications with Annotations
News Highlights:
- Most-Cited All-Time Papers in Two Leading Virology Journals
- Clarivate Highly Cited Researcher (5th Consecutive Year)
- PhD Student Fan Bu Receives Outstanding Research Award
- 2026 Fang Li Research Awards Recipients Announced
- New Nature Communications Study: Novel Ebola Entry Inhibitor
Opportunities:
Links: Linkedin | Twitter | YouTube | Personal Reflections